Electroconvulsive Therapy and All-Cause Mortality in Texas, 1998-2013.

Published

Journal Article

INTRODUCTION: Electroconvulsive therapy (ECT) remains an effective treatment for major depressive disorder. Since 1995, Texas has maintained an ECT database including patient diagnoses and outcomes, and reporting any deaths within 14 days of receiving an ECT treatment, encompassing a total of 166,711 ECT treatments administered in Texas over the previously unreported period of 1998 to 2013. METHODS: Descriptive analysis summarized information on deaths reported during the 16-year period-cause of death, type of treatment (index or maintenance) and patient demographics. Multiple logistic regression of death incidence by treatment session was performed to determine whether patient age, sex, race, diagnosis, or year of treatment was associated with death after ECT. RESULTS: Of those deaths occurring within 1 day of an ECT treatment, the death rate was 2.4 per 100,000 treatments. Looking at all deaths within 14 days of an ECT treatment, the death rate increased to 18 per 100,000 treatments but included all deaths regardless of likelihood of causal association with ECT, for example, accidents and suicides, the latter a leading cause of death among individuals with severe major depression or other disorders for which ECT is indicated. Death rate increased significantly with increasing patient age (P = 0.001) and male sex (P = 0.009), and there was a nonsignificant trend toward increased death amongst patients with bipolar disorder or schizophrenia (P = 0.058) versus depression. CONCLUSIONS: Our data indicate that ECT is in general a safe procedure with respect to the likelihood of immediate death. Suicide remains a significant risk in ECT patients, despite evidence that ECT reduces suicidal ideation.

Full Text

Duke Authors

Cited Authors

  • Dennis, NM; Dennis, PA; Shafer, A; Weiner, RD; Husain, MM

Published Date

  • March 2017

Published In

Volume / Issue

  • 33 / 1

Start / End Page

  • 22 - 25

PubMed ID

  • 27428480

Pubmed Central ID

  • 27428480

Electronic International Standard Serial Number (EISSN)

  • 1533-4112

Digital Object Identifier (DOI)

  • 10.1097/YCT.0000000000000340

Language

  • eng

Conference Location

  • United States